Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages.
Therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signaling pathways. One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell-specific antigens and induce an immune response against the target cancer cell.In addition, monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-α.
Market Analysis and Insights: Global Monoclonal Antibody Therapy Market
The research report studies the Monoclonal Antibody Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Monoclonal Antibody Therapy market size is projected to reach US$ 178100 million by 2026, from US$ 117720 million in 2020, at a CAGR of 7.1% during 2021-2026.
Global Monoclonal Antibody Therapy Scope and Segment
The global Monoclonal Antibody Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody
by Application, this report covers the following segments
Cancer
Autoimmune Diseases
Others
Global Monoclonal Antibody Therapy market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Monoclonal Antibody Therapy key players in this market include:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
Therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signaling pathways. One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell-specific antigens and induce an immune response against the target cancer cell.In addition, monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-α.
Market Analysis and Insights: Global Monoclonal Antibody Therapy Market
The research report studies the Monoclonal Antibody Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Monoclonal Antibody Therapy market size is projected to reach US$ 178100 million by 2026, from US$ 117720 million in 2020, at a CAGR of 7.1% during 2021-2026.
Global Monoclonal Antibody Therapy Scope and Segment
The global Monoclonal Antibody Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody
by Application, this report covers the following segments
Cancer
Autoimmune Diseases
Others
Global Monoclonal Antibody Therapy market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Monoclonal Antibody Therapy key players in this market include:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
1 Market Overview of Monoclonal Antibody Therapy
1.1 Monoclonal Antibody Therapy Market Overview
1.1.1 Monoclonal Antibody Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Monoclonal Antibody Therapy Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Monoclonal Antibody Therapy Market Size by Region (2015-2026)
1.4 Global Monoclonal Antibody Therapy Historic Market Size by Region (2015-2020)
1.5 Global Monoclonal Antibody Therapy Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.1 North America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.2 Europe Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.4 Latin America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
2 Monoclonal Antibody Therapy Market Overview by Type
2.1 Global Monoclonal Antibody Therapy Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Monoclonal Antibody Therapy Historic Market Size by Type (2015-2020)
2.3 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2021-2026)
2.4 Human Monoclonal Antibody
2.5 Humanized Monoclonal Antibody
2.6 Chimeric Monoclonal Antibody
2.7 Murine Monoclonal Antibody
3 Monoclonal Antibody Therapy Market Overview by Application
3.1 Global Monoclonal Antibody Therapy Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Monoclonal Antibody Therapy Historic Market Size by Application (2015-2020)
3.3 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2021-2026)
3.4 Cancer
3.5 Autoimmune Diseases
3.6 Others
4 Global Monoclonal Antibody Therapy Competition Analysis by Players
4.1 Global Monoclonal Antibody Therapy Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2019)
4.3 Date of Key Manufacturers Enter into Monoclonal Antibody Therapy Market
4.4 Global Top Players Monoclonal Antibody Therapy Headquarters and Area Served
4.5 Key Players Monoclonal Antibody Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Monoclonal Antibody Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbvie
5.1.1 Abbvie Profile
5.1.2 Abbvie Main Business
5.1.3 Abbvie Monoclonal Antibody Therapy Products, Services and Solutions
5.1.4 Abbvie Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.1.5 Abbvie Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Monoclonal Antibody Therapy Products, Services and Solutions
5.2.4 Amgen Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.2.5 Amgen Recent Developments
5.3 Glaxosmithkline
5.5.1 Glaxosmithkline Profile
5.3.2 Glaxosmithkline Main Business
5.3.3 Glaxosmithkline Monoclonal Antibody Therapy Products, Services and Solutions
5.3.4 Glaxosmithkline Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Monoclonal Antibody Therapy Products, Services and Solutions
5.4.4 Merck Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.4.5 Merck Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Monoclonal Antibody Therapy Products, Services and Solutions
5.5.4 Novartis Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.5.5 Novartis Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Monoclonal Antibody Therapy Products, Services and Solutions
5.6.4 Roche Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.6.5 Roche Recent Developments
5.7 Johson & Johson
5.7.1 Johson & Johson Profile
5.7.2 Johson & Johson Main Business
5.7.3 Johson & Johson Monoclonal Antibody Therapy Products, Services and Solutions
5.7.4 Johson & Johson Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.7.5 Johson & Johson Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Monoclonal Antibody Therapy Products, Services and Solutions
5.8.4 Novartis Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.8.5 Novartis Recent Developments
6 North America
6.1 North America Monoclonal Antibody Therapy Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapy Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapy Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monoclonal Antibody Therapy Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monoclonal Antibody Therapy Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Monoclonal Antibody Therapy Market Overview
1.1.1 Monoclonal Antibody Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Monoclonal Antibody Therapy Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Monoclonal Antibody Therapy Market Size by Region (2015-2026)
1.4 Global Monoclonal Antibody Therapy Historic Market Size by Region (2015-2020)
1.5 Global Monoclonal Antibody Therapy Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.1 North America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.2 Europe Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.4 Latin America Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Monoclonal Antibody Therapy Market Size YoY Growth (2015-2026)
2 Monoclonal Antibody Therapy Market Overview by Type
2.1 Global Monoclonal Antibody Therapy Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Monoclonal Antibody Therapy Historic Market Size by Type (2015-2020)
2.3 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2021-2026)
2.4 Human Monoclonal Antibody
2.5 Humanized Monoclonal Antibody
2.6 Chimeric Monoclonal Antibody
2.7 Murine Monoclonal Antibody
3 Monoclonal Antibody Therapy Market Overview by Application
3.1 Global Monoclonal Antibody Therapy Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Monoclonal Antibody Therapy Historic Market Size by Application (2015-2020)
3.3 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2021-2026)
3.4 Cancer
3.5 Autoimmune Diseases
3.6 Others
4 Global Monoclonal Antibody Therapy Competition Analysis by Players
4.1 Global Monoclonal Antibody Therapy Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapy as of 2019)
4.3 Date of Key Manufacturers Enter into Monoclonal Antibody Therapy Market
4.4 Global Top Players Monoclonal Antibody Therapy Headquarters and Area Served
4.5 Key Players Monoclonal Antibody Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Monoclonal Antibody Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbvie
5.1.1 Abbvie Profile
5.1.2 Abbvie Main Business
5.1.3 Abbvie Monoclonal Antibody Therapy Products, Services and Solutions
5.1.4 Abbvie Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.1.5 Abbvie Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Monoclonal Antibody Therapy Products, Services and Solutions
5.2.4 Amgen Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.2.5 Amgen Recent Developments
5.3 Glaxosmithkline
5.5.1 Glaxosmithkline Profile
5.3.2 Glaxosmithkline Main Business
5.3.3 Glaxosmithkline Monoclonal Antibody Therapy Products, Services and Solutions
5.3.4 Glaxosmithkline Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Monoclonal Antibody Therapy Products, Services and Solutions
5.4.4 Merck Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.4.5 Merck Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Monoclonal Antibody Therapy Products, Services and Solutions
5.5.4 Novartis Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.5.5 Novartis Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Monoclonal Antibody Therapy Products, Services and Solutions
5.6.4 Roche Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.6.5 Roche Recent Developments
5.7 Johson & Johson
5.7.1 Johson & Johson Profile
5.7.2 Johson & Johson Main Business
5.7.3 Johson & Johson Monoclonal Antibody Therapy Products, Services and Solutions
5.7.4 Johson & Johson Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.7.5 Johson & Johson Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Monoclonal Antibody Therapy Products, Services and Solutions
5.8.4 Novartis Monoclonal Antibody Therapy Revenue (US$ Million) & (2015-2020)
5.8.5 Novartis Recent Developments
6 North America
6.1 North America Monoclonal Antibody Therapy Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapy Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapy Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monoclonal Antibody Therapy Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapy Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monoclonal Antibody Therapy Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
